Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 11/30/2019 (updated monthly) $1,184.9 (M)
Net Assets - Advisor ClassAs of 10/31/2019 (updated monthly) $148.5 (M)

Positions As of 11/30/2019

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 11/30/2019 (updated monthly) $31,295.32(M) $35,269.92(M)
P/B RatioAs of 11/30/2019 (updated monthly) 5.87 5.15
P/E Ratio (12-mo Forward)As of 11/30/2019 (updated monthly) 17.59 16.00
Price to Cash FlowAs of 11/30/2019 (updated monthly) 18.11 16.01

Portfolio Details

Asset AllocationAs of 11/30/2019

[name] [value]
Equity 97.12%
Cash & Cash Equivalents 2.88%

Geographic BreakdownAs of 11/30/2019

[name] [value]
United States 85.32%
Netherlands 3.29%
United Kingdom 2.97%
Cash & Cash Equivalents 2.88%
Denmark 2.51%
Canada 1.31%
Switzerland 1.01%
Germany 0.71%

sector breakdownAs of 11/30/2019

[name] [value]
Biotechnology 80.99%
Pharmaceuticals 11.36%
Life Sciences Tools & Services 4.76%
Cash & Cash Equivalents 2.88%

TOP TEN HOLDINGSAs of 11/30/2019

Issuer Country Industry % of total
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 8.16%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 7.06%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.91%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.79%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.76%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.15%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.65%
HERON THERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.57%
ALEXION PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.28%
NEUROCRINE BIOSCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.22%

Market Capitalization BreakdownAs of 11/30/2019

[name] [value]
<2.0 Billion 14.42%
2.0-5.0 Billion 27.15%
5.0-10.0 Billion 12.37%
10.0-25.0 Billion 6.49%
25.0-50.0 Billion 12.55%
>50.0 Billion 26.68%
N/A 0.33%